HomeNews

News

Understanding the Complete Particular person Behind their Most cancers Prognosis

On the ASCO 2025 Annual Assembly, Dr. Joshua Okay. Sabari sat down with Jackie Herigodt, a affected person advocate, to debate her group,...

Rybrevant Combo Improves Lung Most cancers Outcomes After Tagrisso Failure

Rybrevant plus chemotherapy improved response and delayed illness development for sufferers with EGFR-mutated lung most cancers after Tagrisso remedy.Amongst sufferers with EGFR-mutated non–small...

Explaining Mind Most cancers and Metastases Updates for Sufferers

Consultants shared promising updates on mind most cancers and metastases, together with CATNON trial outcomes and new focused remedies, throughout ASCO 2025.Sufferers with...

How Scars and Journaling Helped Me Embrace Life After Colon Most cancers

Carla Deschamps is now a survivor of colon most cancers after receiving her prognosis in February 2020. Learn Carla's blogs right here!Mhar as soon...

FDA Grants Quick Monitor Designation to Nuvisertib in Myelofibrosis

The FDA granted quick observe designation to nuvisertib for these with intermediate or high-risk myelofibrosis: © inventory.adobe.com.The U.S. Meals and Drug Administration (FDA)...

Hot Topics